Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Action: Physiological Effects

Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus

Clément Raynaud, Wassim Daher, Françoise Roquet-Banères, Matt D. Johansen, Jozef Stec, Oluseye K. Onajole, Diane Ordway, Alan P. Kozikowski, Laurent Kremer
Clément Raynaud
aCentre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wassim Daher
aCentre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Françoise Roquet-Banères
aCentre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matt D. Johansen
aCentre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matt D. Johansen
Jozef Stec
cDepartment of Pharmaceutical Sciences, College of Pharmacy, Marshall B. Ketchum University, Fullerton, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oluseye K. Onajole
dDepartment of Biological, Physical and Health Sciences, Roosevelt University, Chicago, Illinois, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane Ordway
eColorado State University, Department of Microbiology, Immunology & Pathology, Mycobacteria Research Laboratory, Fort Collins, Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan P. Kozikowski
fStarWise Therapeutics LLC, Chicago, Illinois, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Kremer
aCentre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, Montpellier, France
bINSERM, IRIM, Montpellier, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laurent Kremer
DOI: 10.1128/AAC.02548-19
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    Structures of imipenem, cefoxitin, and the lead indole carboxamides 6 and 12 used in this study.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    Synergistic activity of indole-2-carboxamide derivatives with IPM and FOX in vitro. CFU counts of Cpd12 (A) and Cpd6 (B) given alone and in combination with imipenem (IPM) or cefoxitin (FOX). M. abscessus cultures were incubated at 30°C in CaMHB for 5 days in the presence of the indicated compounds (μg/ml) and plated on LB agar prior to CFU enumeration. (C) For CFU determination, the M. abscessus mutant A309P (spontaneous resistant strain to Cpd12 carrying the A309P mutation in MmpL3) was exposed to the indicated antibiotics (μg/ml) at 30°C in CaMHB for 5 days. Graphs represent the mean of three independent experiments completed in triplicate. Data are expressed as the mean ± standard deviation (SD). The statistical test used is a nonparametric Mann-Whitney t test in which the combinations were compared to the drugs alone. ns, nonsignificant; **, P ≤ 0.01; ***, P ≤ 0.001.

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    CFU determination of clinical isolates exposed to Cpd12 given alone or in combination with imipenem (IPM) or cefoxitin (FOX). M. abscessus cultures were incubated at 30°C in CaMHB for 5 days in the presence of the indicated compounds (μg/ml) and plated on LB agar prior to CFU enumeration. Data are expressed as the mean ± SD from three independent experiments completed in triplicate. The statistical test used is a nonparametric Mann-Whitney t test in which the combinations were compared to the drugs alone. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P < 0.0001.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Impact of Cpd12 alone or in combination on intracellular-residing M. abscessus. THP-1 macrophages were infected with M. abscessus S expressing TdTomato (multiplicity of infection [MOI] of 2:1) and treated with the indicated compounds (μg/ml). (A) CFU were determined at day 0 and day 2 postinfection. Data represents the mean ± SD of three independent experiments completed in triplicate. For statistical analysis, a nonparametric Mann-Whitney t test was performed. ***, P ≤ 0.001; ****, P < 0.0001. (B) Percentage of infected THP-1 macrophages at day 0 and day 2 postinfection. Data shown are mean values ± SD for one representative experiment completed in triplicate. One-way analysis of variance (ANOVA) Kruskal-Wallis was used as a statistical test. ****, P < 0.0001. (C) Immunofluorescent fields were taken at day 2 postinfection at magnification 40× (using confocal microscopy) showing the nuclei of macrophages (DAPI in blue) infected with red-fluorescent M. abscessus in the absence or in the presence of the drugs used alone or in combination. Yellow arrows emphasize red-fluorescent M. abscessus (tdTomato) within macrophages. Only intracellular bacteria that were individually observed under the microscope were recorded.

Tables

  • Figures
  • TABLE 1

    Interaction of Cpd6 and Cpd12 with other antibiotics against M. abscessus CIP104536T (smooth strain) assessed by checkerboards REMA in CaMHBa

    TABLE 1
    • ↵a Results are the mean of the FICI ± SD of 3 independent experiments. SUT, sutezolid; IPM, imipenem; FOX, cefoxitin; CFZ, clofazimine.

PreviousNext
Back to top
Download PDF
Citation Tools
Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus
Clément Raynaud, Wassim Daher, Françoise Roquet-Banères, Matt D. Johansen, Jozef Stec, Oluseye K. Onajole, Diane Ordway, Alan P. Kozikowski, Laurent Kremer
Antimicrobial Agents and Chemotherapy Apr 2020, 64 (5) e02548-19; DOI: 10.1128/AAC.02548-19

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Synergistic Interactions of Indole-2-Carboxamides and β-Lactam Antibiotics against Mycobacterium abscessus
Clément Raynaud, Wassim Daher, Françoise Roquet-Banères, Matt D. Johansen, Jozef Stec, Oluseye K. Onajole, Diane Ordway, Alan P. Kozikowski, Laurent Kremer
Antimicrobial Agents and Chemotherapy Apr 2020, 64 (5) e02548-19; DOI: 10.1128/AAC.02548-19
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • TEXT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Mycobacterium abscessus
indole-2-carboxamide
β-lactam
MmpL3
drug synergism
macrophage
therapeutic activity

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596